Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States

Author(s):  Lobb William B, Wilkin Noel E, Holmes Erin R

Issue:  Nov/Dec 2015 - Volume 19, Number 6
View All Articles in Issue

Page(s):  514-520

Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Page 1
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Page 2
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Page 3
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Page 4
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Page 5
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Page 6
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States Page 7

Download in electronic PDF format for $65

Abstract:  Studies have been conducted to assess patient satisfaction with compounded pharmaceuticals and to directly compare compounded pharmaceuticals with their comparable commercial pharmaceuticals. Yet, the economic value of or potential for economic value derived from compounded pharmaceuticals relative to commercial pharmaceuticals is still not known. Therefore, the purpose of this study was to assess and compare compounding and noncompounding pharmacists’ perceptions of the economic value of compounded preparations relative to commercial products. In-depth interviews with 10 compounding pharmacists and physicians who prescribe compounded prescription pharmaceutical preparations were conducted to help develop a self administered questionnaire distributed to 50 compounding and 50 noncompounding pharmacists. Compounding and non-compounding pharmacists’ perceptions differed most often in the context of compounded pharmaceuticals for pediatric patients. However, both groups responded with moderate agreement that compounded prescription treatments are more profitable for the pharmacy than commercial prescription treatments in most therapeutic areas. This research sought to understand the perception of pharmacists of areas for potential direct and indirect economic cost savings as a result of compounding. For all items whereby compounding and non-compounding pharmacists’ ratings were significantly different, compounding pharmacists more strongly believed that compounding pharmaceuticals offered benefit and vice versa. The differences in ratings that were most common were those that directly compared the economic value of compounding and commercial pharmaceuticals, with compounding pharmacists more strongly agreeing with the potential cost savings associated with compounded pharmaceuticals. Based on these findings, prescription compounds are believed to have a benefit to the health system by those who provide them. Future research should proactively explore the economic benefit of compounded preparations compared to conventionally manufactured products to determine the economic value of compounded pharmaceuticals for patients, pharmacies, physicians, and the healthcare system.

Related Keywords: William B. Lobb, RPh, PhD, Noel E. Wilkin, RPh, PhD, Erin R. Holmes, PharmD, PhD, pharmacist survey, pharmacist perceptions, compounded preparations, drug costs, patient satisfaction, drug cost savings, hormone replacement, HRT, skin disorders, high blood pressure, hypertension, pediatrics, children, hospice, compounding pharmacists, non-compounding pharmacists

Related Categories: BUSINESS, PEER-REVIEWED, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Pharmacists' Perceptions of the Economic Value of Compounded Pharmaceuticals: A Comparison of Compounded and Commercial Pharmaceuticals in Select Disease States
Lobb William B
, Wilkin Noel E, Holmes Erin R
Nov/Dec 2015
Pg. 514-520

Patient Satisfaction with Pharmacist Intervention and Consultation in HRT
DiMaggio Jennifer Lyn
, Reed-Kane Dana
Jul/Aug 2003
Pg. 258-263

Specialty Compounding for Improved Patient Care: 2006 National Survey of Compounding Pharmacists
Huffman DC
, Holmes Erin R
Jan/Feb 2008
Pg. 74-82

Patient Satisfaction with Pharmacist Intervention and Consultation in Hormone Replacement Therapy: An Update
Hu Fei-Shu
, Reed-Kane Dana, Draugalis JoLaine R
May/Jun 2006
Pg. 187-192

Specialty Compounding for Improved Patient Care: A National Survey of Compounding Pharmacists
Huffman DC
, Holmes Erin R
Nov/Dec 2006
Pg. 462-468

Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh
Allen Loyd V Jr
Nov/Dec 2003
Pg. 449-450

Patient Interest in Pharmacist-Provided Menopause and Hormone Replacement Therapy Consultations
Branvold Andrea
, Barner Jamie C
Nov/Dec 2003
Pg. 490-494

Patient-centered Care as Value-added Service by Compounding Pharmacists
McPherson Timothy B
, Fontane Patrick E, Day Jonathan R
Jul/Aug 2013
Pg. 339-343

The Science Behind Hormone Replacement Therapy, Part 1
Wepfer Scott T
Nov/Dec 2001
Pg. 462-464

The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene
, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jan/Feb 2014
Pg. 6-12